Other Studies Sample Clauses
Other Studies. If the Research Project does not involve collaboration with Study Investigators, then the Recipient and Recipient’s PI agree to include the following language in an acknowledgment.
Other Studies. If the Research Project does not involve collaboration with Study Investigators, then the Recipient and Recipient’s PI agree to include the acknowledgment found on the XXXX Study website at xxxxx://xxxxx.xxxx.xxx.xxx/xxxx/pubs-policies-and-forms-pg and the following statement. “This manuscript was not prepared in collaboration with investigators of the XXXX Study and does not necessarily reflect the opinions or conclusions of the XXXX Study or the NHLBI.”
Other Studies. Except as set forth in this Article 6, nothing in this Agreement shall (a) prohibit either Party from performing studies other than the Studies, including with its Product used individually or in combination with any other compound or product, in any therapeutic area, or (b) create an exclusive relationship between the Parties with respect to any Product.
Other Studies. If the Research Project does not involve collaboration with Study Investigators, then the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. "The Framingham Heart Study is supported by Contract No. 75N92019D00031 from the National Heart, Lung, and Blood Institute (NHLBI) with additional support from other sources.” “This manuscript was not prepared in collaboration with investigators of the FHS and does not necessarily reflect the opinions or conclusions of the FHS or the NHLBI.”
Other Studies. Each Participating TO shall be responsible for preparing any study or providing any relevant information as directed by the ISO in accordance with Section 3.2 of the ISO Tariff and, if applicable, in accordance with the requirements and timelines in the Participating TO’s
Other Studies. If the Research Project does not involve collaboration with Study Investigators, then the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. "The RURAL Cohort Study is supported by Xxxxxxxx Xx. X00XX000000 from the National Heart, Lung, and Blood Institute (NHLBI) with additional support from other sources.” “This manuscript was not prepared in collaboration with investigators of the RURAL Cohort Study and does not necessarily reflect the opinions or conclusions of the RURAL Cohort Study or the NHLBI.”
Other Studies. The Implementing Committee will also ensure the performance of other studies, research and experimentation determined to be necessary during the AMP.
Other Studies. (a) After the Effective Date and during the term of this Agreement, Sepracor shall have the right to conduct process research, formulation research, and preclinical studies involving R-fluoxetine in support of Patent Rights, and to disclose the results of such studies pursuant to Sections 5.1(a)(iv) or (v) and in furtherance of this Agreement, unless Lilly shall establish to Sepracor's reasonable satisfaction that such disclosure would materially adversely affect Lilly's interest in Product; provided that prior to First Commercial Sale, disclosure of the results of any such studies are first notified to Lilly; and provided, further that prior to initiating any preclinical studies (whether conducted prior to or after First Commercial Sale), Sepracor shall obtain Lilly's prior written approval, which will not be unreasonably withheld.
(b) Except as provided in Section 2.6(a), prior to First Commercial Sale, Sepracor shall not initiate further studies, process research, formulation research or preclinical or clinical trials with R-fluoxetine without the express written consent of Lilly, including the prior written approval of any protocols to be used and any amendments thereto. Sepracor shall request Lilly's written consent by complying with the notice provisions of Article 6, and Lilly may grant or withhold such consent in its sole discretion.
(c) Sepracor and Lilly acknowledge that all Sepracor research results under Sections 2.6(a) and (b) shall constitute Sepracor Know-How; accordingly, Sepracor shall provide to Lilly the results from such research and any background information requested, at no additional cost or royalty. Sepracor shall be permitted to disclose such results to third parties only as provided under Section 5.1 below. At the Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. option of Xxxxx, Xxxxx may have its representative(s) monitor or assist with any preclinical, clinical or other studies approved by Lilly as provided in Section 2.6(b) and conducted by Sepracor.
(d) Sections 2.6(a) and (b) notwithstanding, nothing in this Agreement shall be construed to restrict or limit Sepracor's right to use Product obtained from commercial sources in clinical trials following First Commercial Sale provided that no Proprietary Information is utilized by Sepracor in violation of this Agreement.
Other Studies. Nothing in this Agreement shall (i) prohibit either Party from performing clinical studies other than the Study relating to its own Compound, either individually or in combination with any other compound(s) or product(s), in any therapeutic area, or (ii) create an exclusive relationship between the Parties with respect to any Compound. ARTICLE 3.
Other Studies. 18 2.7 Progress Reports to Sepracor.............................19 2.8